Александрова И. В., Ермолова А. С., Чжао А. В., Артамонов В. В., Рей С. И.

Альбуминовый диализ (МАРС-терапия) у больных с дисфункцией печеночного трансплантата

ЛИТЕРАТУРА
1. Ambrosino G., Cillo U., Varotto S., et al. PDF post liver transplant treated by MARS case report and general consideration // 3 Inter. Simposium on Albumin Dialysis in liver disease. — 2001. — P. 9.
2. Catalina M. V., Barrio J., Anaya F., et al. Hepatic and systemic haemodynamic changes after MARS in patients with acute jn chronic liver failure // Liver International. — 2003. — Vol. 23. — Suppl. 3. — P. 39—43.
3. Covic A., Goldsmith D., Gusbeth-Tatomir P., et al. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion // Liver International. — 2003. — Vol. 23. — Suppl. 3. — P. 21—27.
4. Evenepoel P., Maes B., Wilmer A., et al. Detoxifying capacity and kinetics of the molecular adsorbent recycling system // Blood Purif. — 2003. — V. 21. — N 33. — P. 244—252.
5. Hetz H., Faybik P., Baker A., et al. MARS improves indocyanine green kinetics in primary dysfunction after OLT // 4 Inter. Simposium on Albumin Dialysis in liver disease. — 2002. — P. 47—48.
6. Klammt S., Stange J., Mitzner S. R., et al. Extracorporeal liver support by recirculating albumin dialysis: Analysing the effect of the first clinically used generation of the MARSystem // Liver. — 2002. — Vol. 22. — Suppl. 2. — P. 30—34.
7. Laleman W., Wilmer A., Evenepoel P., et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure // Crit. Care. — 2006. — Vol. 10. — N 4. — P. 108.
8. Lenz K., Hubmann R., Fritsch N., et al. Use of extracorporeal liver assist device (MARS) in a patient with acute on chronic liver failure caused by transplant rejection in chronic Hepatis C. // 4 Inter. Simposium on Albumin Dialysis in liver disease. — 2002. — P. 37—38.
9. Mitzner S. R., Stange J., Klammt S., et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial // Liver Transpl. — 2000. — Vol. 6. — N 3. — P. 277—286.
10. Mitzner S. R., Stange J., Klammt S., et al. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure // J. Am. Soc. Nephrol. — 2001. — Vol. 12. — Suppl. 17. — P. 75—82.
11. Novelli G., Rossi M., Pretagostini R., et al. MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure // Liver. — 2002. — Vol. 22. — Suppl. 2. — P. 43—47.
12. Sen S., Mookerjee R. P., Cheshire L. M., et al. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis // J. Hepatol. — 2005. — Vol. 43. — P. 142—148.
13. Senf R., Klingel R., Kurz S., et al. Bilirubin-adsorption in 23 critically ill patiens with liver failur // Int. J. Artific. Org. — 2004. — Vol. 27. — N 8. — P. 717—722.
14. Stefoni S., Coli L., Cianciolo G., et al. Inflammatory response of a new synthetic dialyser membrane. A randomized crossover comparison between polysulfone and helixone // Int. J. Artif. Organs. — 2003. — Vol. 26. — N 1. — P. 26—32.
15. Steiner C., Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry // Liver. — 2002. — Vol. 22. — Suppl. 2. — P. 20—25.
16. Sturm E., Franssen C. F., Gouw A., et al. Extracorporeal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC) // Liver. — 2002. — Vol. 22. — Suppl. 2. — P. 72—75.